The University of Wisconsin-Madison School of Veterinary Medicine, in collaboration with the Clinical and Translational Science Award One Health Alliance (COHA), has announced its inaugural class of Translational Research Fellows for 2020. These veterinary clinicians …
Research News
UW–Madison Researchers Lead Efforts to Understand, Thwart New Coronavirus
Posted onBack in 2016, when Zika virus first began to cause infections in the Americas, University of Wisconsin-Madison researchers pulled together a coalition of scientists to study the virus and openly share their data for others. …
Flashing Lights May Provide Vital First Test of MS Drug Success
Posted onMeasuring changes in the speed of electrical signals along nerves connecting the eyes to the brain may accurately reflect recovery from myelin loss in multiple sclerosis (MS), according to researchers at the University of Wisconsin–Madison, …
Clinical Trial for Ebola Vaccine Developed at UW–Madison Underway in Japan
Posted onAs of this week, a phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan. Fifteen healthy young men* will receive two doses of …
New Flu Drug Drives Drug Resistance in Influenza Viruses
Posted onBy Kelly April Tyrrell On January 31, 2019, an 11-year old boy in Japan went to a medical clinic with a fever. The providers there diagnosed him with influenza, a strain called H3N2, and sent …
Common Chemical Linked to Rare Birth Defect in Mice
Posted on
A chemical commonly used in consumer and agricultural products to boost the effectiveness of insecticides has been linked to a rare birth defect in mice. The chemical, piperonyl butoxide or PBO for short, is widely used as a “synergist” in household and agricultural insecticides to make the toxic effects of the insecticide longer lasting and to reduce the amount of actual insecticide in a product.
Despite its widespread and growing use, as well as its ubiquity in the environment, the chemical has been little studied. Now, a team led by Robert Lipinski, a professor of comparative biosciences in the University of Wisconsin–Madison’s School of Veterinary Medicine, reports that PBO interferes with the critical signaling pathway dubbed by scientists as sonic hedgehog, resulting in stunted forebrain development and signature facial abnormalities. The study is published this week (Oct. 23, 2019) in the journal Environmental Health Perspectives.
Tiny Capsules Packed With Gene-Editing Tools Offer Alternative to Viral Delivery of Gene Therapy
Posted onNew tools for editing genetic code offer hope for new treatments for inherited diseases, some cancers, and even stubborn viral infections. But the typical method for delivering gene therapies to specific tissues in the body …
Summer Scholars Present Research, Alumna Awarded at National Veterinary Symposium
Posted onThe UW School of Veterinary Medicine (SVM) was well represented at the 2019 National Veterinary Scholars Symposium in Worcester, Massachusetts in July. Twenty-two doctor of veterinary medicine (DVM) students from UW participated in the symposium …
Veterinarians, Physicians to Jointly Explore Links Between Animal and Human Health
Posted onA physician, a veterinarian and a PhD researcher walk into a conference. At the event’s conclusion, the medical doctor says: “I had no idea there were veterinary cardiologists like there are human cardiologists.” This interaction …
From Immersive Education to Crane Rehabilitation, SVM Researchers Earn 2019 Global Health Grants
Posted onTackling everything from mosquitoes to antibiotic resistance, the University of Wisconsin-Madison Global Health Institute (GHI) recently awarded 30 grants and awards to faculty, staff, clinicians and students from across campus, including three recipients from the …